Long-term efficacy of dose intensified interferon-α 2b and ribavirin therapy for hepatitis C in HIV-coinfected patients

被引：0
|
作者：
Mannah, M [1 ]
Rockstroh, JK [1 ]
Gölz, J [1 ]
Klausen, G [1 ]
Dupke, S [1 ]
Stein, L [1 ]
Notheis, G [1 ]
Stoehr, A [1 ]
Mauss, S [1 ]
机构：
[1] Univ Bonn, Neurol Klin, D-53105 Bonn, Germany
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
W901
引用
收藏
页码：A528 / A528
页数：1
相关论文
共 50 条
  • [21] Effect of combination therapy with ribavirin and high-dose interferon-α2b for 24 weeks in chronic hepatitis C
    Abe, S
    Narita, R
    Oto, T
    Tabaru, A
    Otsuki, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (01) : 308 - 312
  • [22] Therapy of acute hepatitis C with interferon-α2b plus ribavirin in a health care worker
    Ertem, GT
    Tulek, N
    Oral, B
    Kinikli, S
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2005, 68 (01) : 104 - 106
  • [23] A prospective study of neuropsychiatric symptoms associated with interferon-α-2b and ribavirin therapy for patients with chronic hepatitis C
    Dieperink, E
    Ho, SB
    Thuras, P
    Willenbring, ML
    PSYCHOSOMATICS, 2003, 44 (02) : 104 - 112
  • [24] Role of Pegylated Interferon-α-2a and Ribavirin Concentrations in Sustained Viral Response in HCV/HIV-Coinfected Patients
    Lopez-Cortes, L. F.
    Valera-Bestard, B.
    Gutierrez-Valencia, A.
    Ruiz-Valderas, R.
    Jimenez, L.
    Arizcorreta, A.
    Terron, A.
    Viciana, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (05) : 573 - 580
  • [25] Efficacy of hepatitis B vaccination and interferon-α-2b combination therapy versus interferon-α-2b monotherapy in children with chronic hepatitis B
    Helvaci, M
    Kizilgunesler, A
    Kasirga, E
    Ozbal, E
    Kuzu, M
    Sozen, G
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (07) : 785 - 791
  • [26] Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin
    Soriano, V
    Núñez, M
    Camino, N
    Maida, I
    Barreiro, P
    Romero, M
    Martín-Carbonero, L
    Garcia-Samaniego, J
    González-Lahoz, J
    ANTIVIRAL THERAPY, 2004, 9 (04) : 505 - 509
  • [27] Comparative study of the efficacy of an induction dose of interferon-α2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C
    Pérez, R
    Jimènez, M
    Crespo, J
    Diago, M
    Enríquez, J
    Vaquero, P
    Solá, R
    Olcoz, JL
    Romero, M
    Salmerón, J
    Blanco, MI
    Oña, M
    Melón, S
    Rodrigo, L
    JOURNAL OF VIRAL HEPATITIS, 2003, 10 (06) : 437 - 445
  • [28] Current management and recommendations on hepatitis B therapy in HIV-coinfected patients
    Lionel Piroth
    Sophie Mahy
    Stanislas Pol
    Fabrice Carrat
    Damien Sene
    Manuel Etienne
    Caroline Lascoux-Combe
    Anne Simon
    Jean-Luc Schmit
    Patrice Cacoub
    Hepatology International, 2013, 7 : 437 - 442
  • [29] Long-term interferon-α2b therapy in chronic hepatitis B.: A prospective multicentre study in Hungary
    Lengyel, G
    Feher, J
    Dalmi, L
    David, K
    Gervain, J
    Gogl, A
    Lonovics, J
    Ozsvar, Z
    Par, A
    Schneider, F
    Tulassay, Z
    CELL INJURY AND PROTECTION IN THE GASTROINTESTINAL TRACT: FROM BASIC SCIENCES TO CLINICAL PERSPECTIVES 1996, 1997, : 305 - 311
  • [30] Interleukin-2 Plus Ribavirin Versus Interferon-α-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-α-2b Treatment
    Mariano Malaguarnera
    Giovanni Pistone
    Sergio Neri
    Marcello Romano
    Alfio Brogna
    Salvatore Musumeci
    BioDrugs, 2004, 18 : 407 - 413
12345